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HeLa Cells and Unjust Enrichment in the Human
Body
Deleso A. Alford, J.D., LL.M *
Henrietta Lacks is buried Clover, Virginia.' She achieved fame and
immortality in the world of science.2 In 1951, Johns Hopkins Hospital
harvested the tissue of Ms. Lacks, a 31-year-old African American woman
diagnosed with cervical cancer to mass produce "HeLa cells."' 3 The money
derived from her cell line produced wonders and scientific breakthroughs in
technology, biology and medicine which "far exceeds that reflected in the
published literature, because it is the reference cell in so many research
laboratories.'A
Ms. Lacks - raced by social construction 5 and gendered by biology for
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Hughes- Harris, Assistant Vice President, Linda Barge-Miles, Esq., Dr. Tanaga Boozer, Dr.
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Reaves, Professor Phebe Poydras, FAMU Law Library Staff and the Editorial staff of
ASLME Edition of Annals of Health Law. I extend the deepest gratitude to my family and
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1.

See generally REBECCA SKLOOT, THE IMMORTAL LIFE OF HENRIETTA LACKS (Crown

Pub. Group 2010) (discussing the life of Ms. Henrietta Lacks and her cells, known as HeLa
cells, the first "immortal" cells to be grown in culture).
2. Lisa Ikemoto, The Racializationof Genomic Knowledge, 27 SETON HALL L. REV. 937,
948 (1997).
3. See SKLOOT, supra note 1, at 86. Henrietta Lacks died within 8 months of her first
visit to John Hopkins from cervical cancer.
4. Howard W. Jones, Jr. et al., George Otto Gey. (1899-1970): The HeLa Cell and a
Reappraisalof its Origin, 38 OBSTETRICS & GYNECOLOGY 945, 948 (1971).
5. See Ian F. Haney Lopez, The Social Construction of Race: Some Observations on
Illusion, Fabrication,and Choice, 29 HARV. C.R.-C.L. L. REV. 1, 30 (1994) (arguing that
"because races are constructed, ideas about race form part of a whole social fabric into which
other relations, among them gender and class, are also woven."). See generally See Richard
Delgado & Jean Stefancic, Critical Race Theory: An Annotated Bibliography, 79 VA. L.
REV. 461 (1993).
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all mankind stood at the crossroads of public health care (circa 1951)6 - in
an apartheid state of reality in the United States and ploughed back into
medicine. The biological uniqueness 7 of her cells allowed scientists and
researchers to benefit society as a whole. In this essay, I place Ms. Lacks'
parts (tissue cells) back into her body to raise a claim of unjust enrichment.
I discuss the ongoing debate as to whether the ownership of cells is a
legally protected interest. I explore historical facts and apply them to eke
out justice for Ms. Lacks and her descendants. I sketch the elements for
unjust enrichment under Restatement (Third) of Restitution and Unjust
Enrichment (2011). The new restatement offers an opportunity to re-visit
the unauthorized taking of and profiting from Ms. Lacks' cell line. Even if
it does not fit expressly within the definition of unjust enrichment, it fits
within the purpose and goals of the concept.
I.

THE DEBATE: LEGALLY PROTECTED INTEREST IN THE BODY?

The legal debate about individuals claiming property interest in their
tissue surfaced in Moore v. Regents of the University of California.8 This
case was subsequently followed by an appeal and a final decision by the
California Supreme Court in 1990. It relied upon policy implications and
the potential chilling effect on research to find that the plaintiff had no
property interest in his excised cells. However, the court acknowledged that
the acquisition and use of Moore's tissue cells constituted a physician's
breach of fiduciary duty. Succinctly put, the court reasoned that a physician
owes a patient a fiduciary duty to the same tissue cells that the patient does
not possess a proprietary interest in the first place. 9 The debate as to the
6.

C. VANN WOODWARD, THE STRANGE CAREER OF JIM CROW

(Oxford Univ. Press 1966)

7 (noting that laws and customs furthered racial ostracism in hospitals among other social
aspects of life).
7. See Terry Sharrer, "HeLa" Herself, Celebrating the Woman Who Gave the World Its
First Cell Line, Scientist, July
1, 2006, available at http://classic.thescientist.com/2006/7//22// (explaining that HeLa cells are unique and grow aggressively
because of:
[a] combination of human papillomavirus 18, which produces a protein that
degrades the p53 tumor suppressor gene protein without mutating p53 itself, and
a mutation with Lacks' HLA supergene family, on chromosome 6, that allowed
severe chromosome damage to occur. The results include such abnormalities as
the long arm and centromere of chromosomes 1 being attached to the long arm of
chromosome 3, and four or five copies of the short arm of chromosome 5 ending
with a centromere.).
8. Moore v. Regents of the Univ. of California, 249 Cal. Rptr. 494, (Cal. Ct. App. 1988),
modified, 793 P.2d 479 (Cal. 1990), cert. denied, 499 U.S. 936 (1991).
9. See Press Release, Berman Institute Scholar Calls for a New Legal, Ethical
Framework For Research With Human Tissue Specimens (June 18, 2010) available at
http://www.bioethicsinstitute.org/web/module/press/pressid/230/interior.asp
(referencing
Javitt, "'[t]he court's reasoning with respect to informed consent is flawed' ... because [it]
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correctness of this decision is often faced with compelling points made by
the concurring and dissenting opinions.' ° It is beyond the scope of this
essay to debate the Moore holding. As Professor Gail Javitt puts it:
[w]hile it is true that there is no legal consensus on the status of human
tissue-although the issue has been the subject of scholarly discussionresolution of the property status is unnecessary in order to impose an
obligation on researchers with respect to prospective contributors of
human tissue. As both Rebecca Skloot's book and public opinion
research reveal, many people do harbor strong possessive, or at least
protective, feelings towards their tissue. Such feelings may find their
source in religious views of the body-as is the case with Henrietta's
daughter, who believed that her mother's soul, in some sense, resides in
her cells. Alternatively, they may reside in notions of bodily integrity, i.e.
the conviction that, as a matter of autonomy, individuals should retain the
power to control the use of their body parts by virtue of1the fact that those
parts originated in, and once were a part of, their body.
I contend that the Moore court acknowledged a property interest in the
patients' spleen that was on one hand subject to being patented by his
physician, yet incapable of proprietary ownership by the patient.12 This
article intends to shed light on the unique facts supporting a claim for unjust
enrichment in the human body of Henrietta Lacks. For purposes of
contextualization, I call for a critical examination of the Moore court's
majority opinion's act of erasing the identity13 of Ms. Lacks as both a
person and/or traceable cell line, commonly referred to as the HeLa cell
line. In a footnote reference, the Moore court states that "[t]he first human
tumor cell line, which still is widely used in research, was isolated in
195 1.,,4 The majority court relegated Ms. Lacks' valuable product line to a
year in time without acknowledgement of her identity. Nevertheless, the
court relied on the absence of authority to not find a property interest in
human tissue cells sui generis in Moore. The court appeared to reason that
since the "first" immortal cell line has not raised a property interest in her
cell line (since 1951) then one does not exists in 1993. The obvious

'failed to distinguish between Moore as patient and Moore as research subject"').
10. Benjamin Appelbaum, Moore v. Regents of the University of California:Now That
the CaliforniaSupreme Court Has Spoken, What Has It Really Said?, 9 N.Y.L. SCH. J. HUM.
RTs. 495, 516-25 (1992).
11. Gail Javitt, Why Not Take All of Me? Reflections on Immortal Life of Henrietta
Lacks and the Status of Participantsin Research Using Human Specimens, 11 MINN. J.L.
Sci. & TECH. 713,750-51 (2010).
12. Michele Goodwin, Formalism and The Legal Status of Body Parts, 2006 U. CHI.
LEGAL F. 317, 327-328 (2006).
13. See Ikemoto, supra note 2, at 948-50.
14. See Moore, 793 P.2d at 488, n. 15.
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silencing of Ms. Lack' valuable contribution (HeLa cells) to society in the
seminal case of Moore goes beyond a lively debate on tissue cells property
ownership. It speaks volumes to a call for justice for Ms. Lacks'
descendants for the benefit conferred to society.
II.

THE CLAIM

Dr. Howard Jones - the first Johns Hopkins physician to diagnose Ms.
Lacks with cervical cancer - notes that, "[s]cientific progress and indeed
progress of all kinds is often made at great cost, such as the sacrifice made
by Henrietta Lacks." 15 This essay frames the so-called "sacrifice" made by
Ms. Lacks in term of unjust enrichment. Most recently, the story of Ms.
Lacks has been met with a degree of astonishment that either warrants utter
disbelief and/or deep gratitude for her "gift., 16 However, the word
"sacrifice" is not an accurate assessment of what happened in the instant
matter. Ms. Lacks' tissue cells were not only taken and commercially used
without her consent, but she was neither informed of the nature of the
proposed procedure, nor its risks of infertility. 17 Upon Ms. Lacks'
admission to Johns Hopkins, she signed an "OPERATION PERMIT,"
which read, "I hereby give consent to the staff of The Johns Hopkins
Hospital to perform any operative procedures and under any anesthetic
either local or general that they may deem necessary in the proper surgical
care and treatment of:
,,18 Ms. Lacks printed her name in the
blank space, which was duly witnessed.1 9 It is without question that Johns

Hopkins, through its physicians, acted within the scope of the expressed
consent form as it relates to putting Ms. Lacks under anesthesia for the

radium cancer treatment to address her diagnosis of invasive cervical
carcinoma.

20

ta

h

I argue that the interference of Henrietta's interest by the

15. Howard W. Jones, Jr., Record of the First Physician to see Henrietta Lacks at the
Johns Hopkins Hospital: History of the Beginning of the HeLa Cell Line, 176 AM. J.
OBSTETRICS & GYNECOLOGY S227, S228 (1997).

16. Nathalie Rothschild, How One Woman's Cells Revolutionised Science, SPIKED, Oct.
28, 2011, available at http://www.spiked-online.com/index.php/site/reviewofbooksarticle
/11347/. See SKLOOT, supra note 1, at 29-30. (noting that during Ms. Lacks' 1951 hospital
visit, Dr. Richard TeLinde, Johns Hopkins top cervical expert believed in using patients from
the public wards usually without their knowledge for research purposes).
17. Arthur Derse, The Ethics of Self-Determination: The Diving Bell and the Butterfly,
in THE PICTURE OF HEALTH 51 (Henri Colt et al. eds. 201 1)(noting that, "[o]ver the past
century, American law and medical ethics newly recognized that '[e]very human being of
adult years and sound mind has a right to determine what shall be done with his [or her] own
body.' Not only must the patient give consent for medical treatment, but the patient must
also be informed of the nature of the proposed procedure, as well as the benefits, risks, and
alternatives").
18. See SKLOOT, supra note 1, at 31.
19. Id.
20. See id. at 31-33.
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wrongful taking and transferring of tissue cells occurred when the surgeon
on duty "shaved two dime-sized pieces of tissue from [Ms. Lacks'] cervix:
one from her tumor, and one from the healthy cervical tissue"21 for research
purposes without her knowledge or consent. This act exceeded the scope of
the operation permit signed by Ms. Lacks.
Furthermore, the application of a critical race feminist lens would allow
one to critique the "her-story" narrative of Ms. Lacks' multidimensional
existence as a raced, classed, and gendered patient marginalized in history,
at best. At the time of Ms. Lacks' treatment, it had been the practice of
Johns Hopkins to warn patients about the risks of fertility loss before cancer
treatment.2 2 Ms. Lacks signed a consent form for cancer treatment.23 During
this time, the accepted treatment consisted of putting strips of lead inside
the vagina to protect the colon and lower spine from radiation. 24 Ms.
Lacks' doctors failed to apprise her of the risks of infertility before the
cancer treatment, in direct violation of the hospital's practice. 25 Ms. Lacks'
medical record indicates that "if she had been told [of the risks] before, she
would not have gone through with treatment., 26 It appears that Ms. Lacks'
denial of identity as a "woman" worthy of being warned of the potential
inability to reproduce was overshadowed by her intersecting identity as a
"poor Southern tobacco farmer who worked the same land as her [enslaved]
ancestors ' '27 in the body of a 31 year-old wife, mother of five gaining free
public health care.
As Skloot contends, "[m]any scientists believed that since patients were
treated for free in the public wards, it was fair to use them as research
subjects as a form of payment., 28 Another notion of "fairness" will be
addressed in terms of unjust enrichment as to Ms. Lacks and her
descendants. The nonconsensual transfer of tissue cells for research
purposes and/or substantial profit did not end with Ms. Lacks. It is well
21. See id. at 33.
22. Id. at 47. See also Richard W. TeLinde, Hysterectomy: Present-Day Indications,
JMSMS, July 1949, at 829, (noting in part, "[tihe woman on whom hysterectomy is
contemplated is entitled to a simple explanation of the facts. She may be truthfully told that
aside from the loss of reproductive function and the inconvenience of menstruation she may
expect no physical or psychical change.").
23. See Ruth R. Faden, Informed Consent and ClinicalResearch, KENNEDY INST. ETHICS
J,, Dec. 1996, at 356, 256 (explaining that, "[d]uring the forties and fifties, duties to obtain
informed consent, whether for treatment or for research, were simply not part of the doctorpatient experiences."). This author believes that Johns Hopkins failure to adhere to its own
custom of warning its female patients of the potential loss of fertility amounts to a failure to
obtain informed consent.
24. See SKLOOT, supra note 1, at 46-47.
25. Id.at 47-48.
26. Id. at 48.
27. The Lacks Family (2011), http://www.lacksfamily.com.
28. See SKLOOT, supra note 1, at 29-30.
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documented that medical representatives continued to take blood and tissue
cell samples from her surviving family members without informed
consent. 9 I submit that Ms. Lacks' descendants have a viable claim for
unjust enrichment under Restatement (Third) of Restitution and Unjust
Enrichment.
III.

THE RELIEF: RESTATEMENT (THIRD) OF RESTITUTION AND UNJUST
ENRICHMENT

Professor Andrew Kull, Reporter for the Restatement (Third) of
Restitution and Unjust Enrichment ("Restatement") states his proposition
on the law of restitution as "be[ing defined exclusively in terms of its core
idea, the law of unjust enrichment., 30 Professor Kull points out that, "it
would be axiomatic (i) that no liability could be asserted in restitution other
than one referable to the unjust enrichment of the defendant, and (ii) that the
measure of recovery in restitution must in every case be the extent of the
defendant's unjust enrichment.",3 1 Based upon the unique facts surrounding
Ms. Lacks, I argue that the impossibility of measuring the defendant's
unjust enrichment with mathematical exactness should not prevent
restitution required under a notion of transformative justice.
Section 44 of the Restatement (Third) of Restitution and Unjust
Enrichment states that:
(1). A person who obtains a benefit by conscious interference with a
claimant's legally protected interests (or in consequence of such
interference by another) is liable in restitution as necessary to prevent
unjust enrichment, unless competing legal objectives make such liability
inappropriate.
(2). For purposes of subsection (1), interference with legally protected
interests includes conduct that is tortuous, or that violates another legal
duty or prohibition (other than a duty imposed by contract), if the conduct

29.

KARLA FC HOLLOWAY, PRIVATE BODIES, PUBLIC TEXTS: RACE, GENDER AND A

CULTURAL BIOETHICS

19 (Duke Univ. Press 2011);

Susan H. Hsu et al., Genetic

Characteristicsof the HeLa Cell, 191 SCIENCE 392, 392 (1976) (noting that "in an effort to
clarify the characteristics of the HeLa cell and establish its probable genotype for betterknown polymorphisms, we studied HLA and other markers in the surviving husbands and
children of Henrietta Lacks").
30. Andrew Kull, RationalizingRestitution, 83 CAL. L. REV. 1191, 1196 (1995). I want
to personally thank Professor Kull for the inspiration to use the Restatement as a legal
anchor on behalf of Ms. Lacks after his presentation "Restitution Revival - The Restatement
(3d) of Restitution and Unjust Enrichment" at the Southeastern Association of Law Schools
(SEALS) 2010 Annual Meeting.
31. Id.
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32
constitutes an actionable wrong.

Johns Hopkins' practice of taking tissue cells without Ms. Lacks'
knowledge or consent amounted to a conscious interference with her legally
protected interests, thereby rendering the institution liable for restitution to
prevent unjust enrichment. Johns Hopkins nonconsensual transfer of Ms.
Lacks' tissue cells for research purposes led to the first immortal cell line
referenced as HeLa cells. The HeLa cells' benefit to society, including
helping advance in vitro fertilization, cloning, and gene mapping 3 was
made possible by Johns Hopkins' nonconsensual transfer in 1951. The
viability of a claim for unjust enrichment involving the body parts at issue
in Moore has been thoroughly addressed by Michael Traynor in the
Restatement.34 Traynor correctly argues that "[i]f Moore was wronged, a
remedy is appropriate that is in tune with the principle that restitution
should be available when a person is 'unjustly enriched at the expense of
another."'' 35 Further, he adds, "[a]s between awarding damages for an
unmeasurable and uncertain loss of the right to informed consent and
awarding restitution of a reasonable portion of any net profit based on an
evaluation of the relative values of the contributions, restitution may be the
preferable remedy, at least in some cases. 36 The Restatement, in section 44,
seemingly adopted Traynor's view as to recognizing a claim for unjust
enrichment in its useful illustration derived from the facts of Moore37:
Patient consults Doctor for treatment of a rare blood disorder. Doctor
recognizes that certain characteristics of Patient's blood cells make them
unusually valuable for research purposes. Without request or disclosure
to Patient, Doctor retains the blood samples taken from Patient on
subsequent visits and sells them to interested researchers, realizing a total
of $25,000. Doctor's decision to examine samples of Patient's blood is
medically appropriate; the same amount of blood would have been drawn
from Patient in any event; and Patient suffers no physical injury from
Doctor's activities. By the law of the jurisdiction, Patient cannot maintain
an action for conversion of blood or other tissue removed from his body
for medical purposes. On the other hand, local law governing disclosure
by physicians and informed consent by patients is violated when Doctor,
without disclosure or consent, makes any use of Patient's blood
32.

Restatement (Third) of Restitution & Unjust Enrichment § 44 (2011).

33. Annette Dula, Research and Racism: Miss Evers' Boys, in THE PICTURE OF HEALTH
83 (Henri Colt et al. eds. 2011).
34. Michael Traynor, The Unjust Enrichment Claim in Moore v. Regents, 9
BIOTECHNOLOGY L. REP. 240, 241-45 (1990).
35. Id. at 241.
36. Id. at 244.
37. See Restatement (Third) of Restitution & Unjust Enrichment § 44 cmt. b, illus. 11,
rept. note b (2011).
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Patient may recover $25,000
for purposes unrelated to his care of Patient.
38

from Doctor by the rule of this section.

A similar case subsequent to Moore addressing unjust enrichment for the
"new tort of nondisclosure of research or economic interest ' 39 isGreenberg
v. Miami Children's Hospital Research Institute.40 Professor Mark A.
Rothstein points out that in Greenberg, Judge Moreno paid particular
attention to the fact that the plaintiffs' asserted "that they would not have
made their contributions to the research had they known of the defendant's
' This essay unearths
intentions to commercialize their genetic material. 41
the marginalized aspect of Ms. Lacks' assertion that she would not have
agreed to the cancer treatment had the Johns Hopkins physicians informed
her of the potential risk for infertility pursuant to their standard practice.
A.

PrimaFacie casefor Unjust Enrichment

Ms. Lacks' descendant's claim for unjust enrichment must satisfy certain
elements to prove a prima facie case. 42 Generally, the elements include: a
benefit conferred upon the defendant by the plaintiff; awareness,
appreciation, or knowledge by the defendant of the benefit; and acceptance
or retention of the benefit by the defendant under such circumstances as to
43
make it inequitable for the defendant to retain the benefit to plaintiff.
Pursuant to section 1 of the Restatement, "[a] person who is unjustly
enriched at the expense of another is subject to liability in restitution. 4 4
1.

Benefit Conferred

The benefits conferred by Ms. Lacks' HeLa cell line can be summed up
in this way, HeLa, the first human cells to grow outside the body, have been
38.
39.

Id. atillus. 11.
Traynor, supra note 34, at 241 (noting that:
...in the absence of recognizable personal injury and accompanying norms of
compensability, or property damage and accompanying standards of market
value, there are no established standards for determining damages for the new tort
of nondisclosure of research or economic interest. Moreover, the potential
liability for damages is open ended and is not necessarily limited to the
defendants [sic] gain.).

40. Greenberg v. Miami Children's Hospital Research Institute, Inc., 264 F. Supp. 2d
1064 (S.D. Fla. 2003).
41. Mary R. Anderlik & Mark A. Rothstein, Current In Contemporary Ethics, 31 J.L.
MED. & ETHICs 450, 452 (2003).
42. Debra L. Greenfield, Greenberg v. Miami Children'sHospital: Unjust Enrichment
and the Patenting ofHuman Genetic Material,15 ANNALS HEALTH L. 213, 217 (2006).
43. Id.
44. Restatement (Third) of Restitution & Unjust Enrichment § 1 (2011).
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used in more than 60,000 experiments involving leukemia, Parkinson's
disease and AIDS. They were instrumental in developing "the polio
vaccine, chemotherapy, cloning, gene mapping, [and] in vitro
fertilization. 45 Due to the unique nature of Ms. Lacks' cells, they continue
to play a vital role in medical advances worldwide.46 However, a more
telling narrative that fills the gap between Ms. Lacks' benefit conferred and
value gained in return is as follows: "[e]ven though Henrietta's cells
launched a multimillion-dollar industry that sells human biological
materials, the family never saw any of the profits, and for decades after her
decade, many of her descendants struggled in Baltimore, often going years
without health insurance. ' ' 7
2.

Awareness, Appreciation, or Knowledge by the Defendant of the
Benefit
a.

Johns Hopkins, April 10, 1951

Dr. George Gey, head of Johns Hopkins' tissue culture research lab stood
on national television holding a vial containing Ms. Lacks' cells as "he
explained that his lab was using [the] cells to find ways to stop cancer. He
said, "[i]t is quite possible that from fundamental studies such as these that
a way by which cancer cells can be damages or
we will be able to learn
48
completely wiped out."

Robert Stevenson of the American Association of Tissue Banks put it
this way, "'[t]he initial importance of the HeLa cells was clear very
quickly... [and] by growing easily and abundantly, they became the model
system to use for the isolation of poliovirus. When this became available, it
meant immediately that you could culture patients in a routine and
inexpensive way and determine if they were infected with polio." 49
45.

Dwight Garner, A Woman's Undying Gift to Science, N.Y. TIMES, Feb. 3, 2010, at

C I, availableat http://www.nytimes.com/2010/02/03/books/03book.html.
46. Johns Hopkins Inst. for Clinical & Transitional Research, The Henrietta Lacks
Memorial Lecture Series (2011), http://ictr.johnshopkins.edu/ictr/2010/10/the-henriettalacks-memorial-lecture-series.html [hereinafter Johns Hopkins].
47. The Lacks Family, supra note 27.
48. SKLOOT, supra note 1, at 57. See also Van Smith, Wonder Woman: The Life, Death,
and Life After Death of Henrietta Lacks, Unwitting Heroine of Modern Medical Science,
BALTIMORE CITY PAPER, Apr. 17, 2002, available at http://www.citypaper.com/news/story
.asp?id=3426.
49. Rebecca Skloot, An Obsession with Culture, PITT MAG., Mar. 2001,
http://www.pittmag.pitt.edu/mar2001/
culture.html (stating that:
Gey and his colleagues soon showed that HeLa cells were more sensitive to polio
than some primate cells then used for testing the vaccine. Almost immediately,
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Johns Hopkins - From its Official Statement About HeLa Cells and
Their Use - February 1, 2010

The following statement issued by Johns Hopkins addresses some
question raised surrounding the release of Skloot's book about the lack of
informed consent from Ms. Lacks or her family to permit the use of her
cells for scientific research, and about some financial issues related to their
use:
Johns Hopkins Medicine sincerely acknowledges the contribution to
advances in biomedical research made possible by Henrietta Lacks and
HeLa cells. It's important to note that at the time the cells were taken
from Mrs. Lacks' tissue, the practice of obtaining informed consent from

cell or tissue donors was essentially unknown among academic medical
centers. Sixty years ago, there was no established practice of seeking
permission to take tissue for scientific research purposes. The laboratory
that received Mrs. Lacks' cells had arranged many years earlier to obtain
such cells from any patient diagnosed with cervical cancer as a way to
learn more about a serious disease that took the lives of so many. Johns
Hopkins never patented HeLa cells, nor did it sell them commercially or
benefit in a direct financial way. Today, Johns Hopkins and other
research-based medical centers consistently obtain 50consent from those
asked to donate tissue or cells for scientific research.
This essay does not raise the unjust enrichment claim based on Johns
Hopkins' lack of a duty to seek informed consent for research purposes in
1951, but for the institution's (through its physicians) breach of a fiduciary
duty to the patient as to their failure to inform her of the attendant risks of
infertility prior to gaining Ms. Lacks' written consent to cancer treatment as

evidenced by the OPERATION PERMIT. The nonconsensual transfer of
Ms. Lacks' tissue cells continues to benefit science and technology in a way
the National Foundation for Infantile Paralysis established facilities at the
Tuskegee Institute for the mass production and distribution of HeLa cells, some
600,000 cultures which they shipped around the country. But that was just the
beginning. Gey gave HeLa cells to researchers around the world-often flying
with test tubes in his breast pocket for safety-providing a tool that would help
uncover the secrets of cancer, viral growth, protein synthesis, the human
genome... the list goes on. Cosmetic companies bought HeLa cells by the
millions to test their products for side effects. And though Henrietta never
traveled farther than the day she left her native Virginia for Baltimore, her cells
sat in nuclear test sites from America to Japan and multiplied in a space shuttle
far above Earth.).
50. Press Release, Johns Hopkins Medicine, A Statement From Johns Hopkins Medicine
About Hela Cells and Their Use (Feb. 1, 2010), http://www.hopkinsmedicine.org/news/
Media/releases/AStatementFromJohnsHopkinsMedicineAboutHeLaCells and Their
Use.

HeLa Cells and Unjust Enrichment

2012]

that neither Ms. Lacks nor her descendants profited from.
3.

Acceptance or Retention of an Inequitable Benefit

Ms. Lacks' tissue cells were taken and transferred at the hands of Johns
Hopkins. The institution and its researchers accepted the notoriety of being
the laboratory site of the first "immortal" human cell culture line. Ms.
Lacks is a sum of her parts worthy of restitution for the interference of her
protected interest. She received nothing in return for the nonconsensual
transfer of her valuable cell line. Upon her death, Ms. Lacks' descendants
have yet to profit from the benefit conferred. 5 1
Accordingly, "[r]estitution as a measure of recovery matters precisely
when defendant's gain exceeds plaintiffs provable loss, either because
plaintiff's loss is small or because it is hard to prove. 52 As to Ms. Lacks's
multi-dimensional existence as a raced, gendered, and classed patient, the
right to "own" one's power of decision making to date has not been
adequately addressed.53 The application of unjust enrichment would
acknowledge the failure of Johns Hopkins to see Ms. Lacks as worthy of
explaining the attending risk of the loss of reproductive capacity before she
signed the operation permit for cancer treatment.
IV.

TRANSFORMATIVE JUSTICE

"Lady Justice must remove her blindfold, and develop a keen sense of
sight, which will allow for deliberate vision calculated towards an
application of principles of social equity. 54 A notion of transformative
justice should be firmly rooted in the ethical principle of justice.5 Justice
does not allow us to continue the denial of Henrietta Lacks' as a person (the
sum of her parts) due to the public narrative that continues to benefit society
51. See Patricia Cohen, Returning the Blessings ofan Immortal Life, N.Y. TIMES, Feb. 4,
2011, availableat http://www.nytimes.con2011/02/05/books/051acks.html.
52. Douglas Laycock, The Scope and Significance of Restitution, 67 TEX. L. REV. 1277,
1288 (1989).
53. George J. Annas , Blinded by Science, 9 Biotechnology L. Rep. 245, 247 (1990)
(explaining that in Moore, Justice Broussard's dissenting opinion argued that the majority
was confusing "the right to control one's body parts after removal with the right to control
them prior to removal.").
54. John Blum, Is Justice for One Justice for All? The Dilemma of Public Health
Enforcement in an Interconnected World, 36 LOYOLA U. CHI. L.J. 349, 362 (2005)
(advocating for a public health justice principle that balances the impact of policies on
individuals both nationally and internationally).
55.
TOM L. BEAUCHAMP & JAMES F. CHILDRESS, PRINCIPLES OF BIOMEDICAL ETHICS 12
(noting justice as one of the "four principle" approach to Bioethics). See also Ruqaiijah
Yearby, Good Enough To Use For Research, But Not Good Enough To Benefit From the
Results of That Research: Are the ClinicalHIV Vaccine Trials In Africa Unjust? 53 DEPAUL
L. REV. 1127, 1132-38 (2004) (exploring the principle of justice and its application to
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at-large from the use of her parts (tissue cells) as a cell line without
acknowledging any obligation for Ms. Lacks' descendants to be made
whole.5 6 The principles of social equity mandate that we acknowledge the
salient issues of race, gender, class, and medicine that penetrated our public
healthcare system both then and now. A public sense of justice for Ms.
Lacks' family is worthy of due praise for taking steps to recognize her
legacy.
Rebecca Skloot founded a non-profit foundation with a mission to show
appreciation for those who have contributed to science in the way Ms.
Lacks has. In fact, her foundation has directly impacted the lives of Ms.
Lacks' descendants by providing a high-tech hearing aid for one of her
sons, truck repairs for another son, new teeth for a granddaughter, braces
for a great-granddaughter, and tuition, books, and fees for five of her
grandchildren and great-grandchildren. 7 Skloot is also trying to raise over
$125,000 to pay the medical costs associated with the quadruple-bypass
surgery for one of Henrietta's sons. 8 She was instrumental in ensuring that
Henrietta's three surviving sons were hired as consultants for an HBO film
being produced by Oprah Winfrey's Harpo Films and screenwriter Alan
Ball. 59 Additionally, individual readers - cancer survivors and scientists have contributed much of the $50,000 to the foundation. 60 The Johns
Hopkins Institute for Clinical and Translational Research is the establishing
sponsor of the Henrietta Lacks Memorial Lecture Series. 61 It is

[a]n annual reminder of the gratitude, respect, and clear communication
due to all research participants.... By coming together each year to
remember the woman behind this lifesaving, world-changing
development in biomedical science, the Johns Hopkins research
community
will never again forget that HeLa stands for Henrietta
62
Lacks.

Johns Hopkins also established financial awards including the Henrietta
Lacks East Baltimore Health Sciences Scholarship, sponsored by the Johns
Hopkins Health System, an award of up to $10,000 per year to support
promising graduates of Paul Laurence Dunbar High School, 63 as well as the
56. See HOLLOWAY, supra note 29, at 154-55 (noting that Ms. Lacks' story is not only
"important in its individual sense, [but] the wrong perpetrated on her family after her death is
read into a narrative of black death and dying that has made race mater").
57. Cohen, supra note 51.
58. Id.
59. Id.
60. Id.
61. Johns Hopkins, supra note 46.
62. Id.
63. Johns Hopkins Inst. for Clinical & Transitional Research, Where Science and
Henrietta Lacks East Baltimore Health Sciences Scholarship, sponsored by the Johns

2012]
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Henrietta Lacks Award for Community-University Collaboration,
sponsored by the Johns Hopkins Urban Institute, which provides a $15,000
annual award to recognize outstanding, pre-existing community-university
collaborations in Baltimore. 64
V.

CONCLUSION

In conclusion, Ms. Lacks entered the free, colored ward of Johns
Hopkins as a patient and unknowingly became a research subject, yielding
the first immortal cell line - and also a valuable product line - to medical
science and society alike. Johns Hopkins failed to adhere to its own
standard practice of informing its female patients of the attendant risks of
infertility prior to obtaining a signed consent form for cancer treatment
from Ms. Lacks. To date, her descendants have not benefited from a fair
apportionment of the subsequent profits gained, resulting in a viable claim
for unjust enrichment under Restatement (Third) of Restitution and Unjust
Enrichment.
The Lacks matter provides an opportunity to strike an equitable balance
between the medical community's need for biotechnology research and the
"financial needs of the patient community and society as a whole., 65 I offer
a new way to think about an approach to bioethics, torts, and race.
Scientists and researchers not only gained massive profits and valuable
medical knowledge from HeLa cells without granting any financial benefit
to Ms. Lacks' descendants, but continued to take blood from the surviving
family members without their informed consent in order to further study the
HeLa cells. Societal constructions of race, gender, and class defined Ms.
Lacks' body and marginalized her existence while profiting from the cells
her body produced. The fact that Ms. Lacks' descendants have not received
any compensation under current legal regimes for the taking of and
profiting from HeLa cells raises bioethical concerns regarding cell
ownership. The Restatement is a viable means to address the notion that the
non-consensual transfer of Henrietta's cells amounts to an interference with
her protected interest for which restitution is due. The Restatement not only
provides a potential remedy for the descendants of Henrietta Lacks, but
further elaborates on the illustration recognizing restitution for interference
Hopkins Health System, Connect (Oct. 7, 2010), http://ictr.johnshopkins.edu/mt/mtsearch.cgi?search=Henrietta+Lacks+East+Batimre+Heath+Sciences+Scholarship%2C+sp
onsored+by+the+Johns+Hopkins+Health+System%2C+&IncludeBlogs= 16&limit=20.
64. Johns Hopkins Inst. for Clinical & Transitional Research, When Science and UHI
Henrietta Lacks Memorial Award Connect (Jun. 15, 2011), http://ictr.johnshopkins.edu/
mt/mtsearch.cgi?search-uhi+Henrietta+lacks+Memorial+Award&IncludeBlogs= 16&limit=
20.
65. Luisa A.M. Giuffrida, Moore v. Regents of the University of California:Doctor, Tell
Me Moore! 23 PAC. L.J. 267, 313 (1991).
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with other protected interests, such as cells in the human body.
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